Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Sponsor

Avencell Therapeutics Inc.

United States 500 Forge Road Suite 320, 02472-2266, United States

About the sponsor

Avencell Therapeutics Inc. focuses its clinical research on aggressive blood cancers, with activity in acute myeloid leukemia and relapsed/refractory B-cell non-Hodgkin lymphoma as well as chronic lymphocytic leukaemia.

  • Acute myeloid leukemia
  • Relapsed/refractory B-cell non-Hodgkin lymphoma
  • Chronic lymphocytic leukaemia

The sponsor’s portfolio is centered on difficult-to-treat hematologic cancers where new cellular therapies are being explored.

About Specializations

Avencell Therapeutics Inc. runs clinical trials in conditions such as Chronic lymphocytic leukaemia, B-cell lymphoma, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

Chronic lymphocytic leukaemia+1

Recruiting
InvestigationalNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:ALLO-QUADCAR01-T
  • Sponsor:Avencell Therapeutics Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.